Medical News

RSS

FDA accepts Vertex KALYDECO NDA for six-month Priority Review

Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for KALYDECOTM (ivacaftor) and granted the company's request for six-month Priority Review.

16 Dec 2011

UV rays help prevent spread of chickenpox

Ultraviolet rays help prevent the spread of chickenpox, meaning people in milder climates are more at risk of catching the disease, according to new research. The discovery could lead to new ways of preventing chickenpox and its more severe relative, shingles.

16 Dec 2011

Scientists discover gene that causes Weaver syndrome

Scientists have found a gene that causes Weaver syndrome, a rare genetic disorder that typically causes large size at birth, tall stature, developmental delay during childhood, and intellectual disability.

16 Dec 2011

Viewpoints: Wyden and Ryan on their Medicare plan; Frist on the need for international health aid

Few issues draw more heated partisan rhetoric than the future of Medicare. Seniors are a reliable and powerful voting bloc, and both Republicans and Democrats are guilty of exploiting Medicare to frighten and entice voters. But turning discussions of Medicare's future into the third rail of American politics does nothing to guarantee that Medicare will continue to be a lifeline for America's seniors.

16 Dec 2011

Older people with visual impairment can benefit from Tai Chi

Practicing Tai Chi improves the balance control of older people with visual impairment demonstrates research published today in Age and Ageing, the British Geriatrics Society's scientific journal.

16 Dec 2011

NACP and MAPT polymorphisms interact to influence rate of Parkinson's progression

Parkinson's disease is marked by the abnormal accumulation of α-synuclein and the early loss of dopamine neurons in the substantia nigra region of the brain. A polymorphism in the promotor of α-synuclein gene known as NACP-Rep1 has been implicated as a risk factor for the disease.

16 Dec 2011

Critical Diagnostics receives FDA clearance for Presage ST2 Assay

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, announced today that the U.S. Food and Drug Administration has cleared the company's Presage ST2 Assay for use as an aid in assessing the prognosis of patients diagnosed with chronic heart failure.

16 Dec 2011

Serotonin, wnt are in charge of asymmetrical right-left development in embryos

Spleen to the left, appendix to the right: In order for the body to sort itself out properly, two substances have to trigger a complex chain reaction, according to the latest findings at the University of Hohenheim.

16 Dec 2011

Metabolomx' colorimetric sensor array can identify subtype of lung cancer

Metabolomx, a diagnostic company focused on the detection of the metabolomics signature of cancer from exhaled breath, today announces publication of results from the first clinical study demonstrating a breath test that can both detect lung cancer and differentiate between types of lung cancer in humans.

16 Dec 2011

Scientists uncover critical genetic mutation in patients with MDS

Scientists have uncovered a critical genetic mutation in some patients with myelodysplastic syndromes - a group of blood cancers that can progress to a fatal form of leukemia.

16 Dec 2011

Hologic receives FDA approval for Cervista HTA system to detect cervical cancer

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration (FDA) has approved its Cervista HTA (high throughput automation) system for use with the Company's previously approved Cervista human papillomavirus (HPV) HR test.

From Hologic, Inc. 16 Dec 2011

Ensign declares quarterly cash dividend of $0.06 per share

The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share of Ensign common stock, payable on or before January 31, 2012 to shareholders of record as of December 31, 2011.

16 Dec 2011

Antimalarial drugs administered during pregnancy safer than contracting malaria, study suggests

"Antimalarial drugs are safer for pregnant women than contracting the disease," according to a study from the University of Oxford published in the journal Lancet Infectious Diseases on Tuesday that "assessed the effects of malaria and its treatment in the first trimester of pregnancy," HealthCanal.com reports.

16 Dec 2011

Decision support tool for objective diagnostics of Alzheimer's

European PredictAD project, lead by Principal Scientist Jyrki Lötjönen from VTT Technical Research Centre of Finland, has developed a decision support tool for objective diagnostics of Alzheimer's disease.

15 Dec 2011

New $100M Cooper Cancer Institute in Camden to break ground in April 2012

Sandra and George Norcross today announced a $5 million pledge to Cooper University Hospital. It is the first commitment in a $50 million capital campaign to help fund the rapid expansion of one of New Jersey's preeminent medical centers.

15 Dec 2011

University of Southampton receives ERC grant to support research into enhanced NMR

New research from the University of Southampton could lead to enhanced MRI scans, producing brighter and more precise images, and potentially allowing the detection of cancerous cells before they cause health problems.

15 Dec 2011

Virco Lab launches HIV/AIDS EHR technology

Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.

15 Dec 2011

Study: Many prescription drugs use phthalates as inactive ingredients

Researchers from Boston University's Slone Epidemiology Center (SEC), in collaboration with Harvard School of Public Health, have found numerous prescription and over-the-counter drugs and supplements use certain chemicals called phthalates as inactive ingredients in their products.

15 Dec 2011

ONC gives gift with vision to reduce blindness and mortality among children

This holiday season, Ocean Nutrition Canada (ONC) is giving a gift with vision. ONC, the largest supplier of Omega-3 EPA/DHA ingredients in the world, is helping to reduce blindness and mortality amongst children in the developing world by donating five million doses of vitamin A to Vitamin Angels.

15 Dec 2011

FIND, NUS collaborate to identify novel biomarkers for TB diagnosis

A research team from the National University of Singapore (NUS) Singapore Lipidomics Incubator (SLING) is collaborating with the Foundation for Innovative New Diagnostics (FIND) to identify novel target molecules to be employed as biomarkers for the detection of active tuberculosis.

15 Dec 2011